Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $4,580 | 2 | 99.2% |
| Food and Beverage | $36.44 | 2 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $4,580 | 2 | $0 (2023) |
| Pinnacle Biologics, Inc | $25.88 | 1 | $0 (2024) |
| Avanir Pharmaceuticals, Inc. | $10.56 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $25.88 | 1 | Pinnacle Biologics, Inc ($25.88) |
| 2023 | $1,080 | 1 | Otsuka Pharmaceutical Development & Commercialization, Inc. ($1,080) |
| 2022 | $3,500 | 1 | Otsuka Pharmaceutical Development & Commercialization, Inc. ($3,500) |
| 2017 | $10.56 | 1 | Avanir Pharmaceuticals, Inc. ($10.56) |
All Payment Transactions
4 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/02/2024 | Pinnacle Biologics, Inc | Photofrin (Drug) | Food and Beverage | Cash or cash equivalent | $25.88 | General |
| Category: Oncology | ||||||
| 06/26/2023 | Otsuka Pharmaceutical Development & Commercialization, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,080.00 | General |
| 11/17/2022 | Otsuka Pharmaceutical Development & Commercialization, Inc. | — | Consulting Fee | Cash or cash equivalent | $3,500.00 | General |
| 04/12/2017 | Avanir Pharmaceuticals, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $10.56 | General |
| Category: pseudobulbar affect (PBA) | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 119 | 404 | $78,148 | $25,023 |
| 2022 | 3 | 100 | 324 | $65,250 | $21,379 |
| 2021 | 3 | 117 | 383 | $75,998 | $26,591 |
| 2020 | 5 | 137 | 298 | $50,847 | $15,676 |
All Medicare Procedures & Services
14 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 32 | 125 | $31,750 | $10,587 | 33.3% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2023 | 40 | 159 | $25,758 | $7,771 | 30.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 47 | 120 | $20,640 | $6,665 | 32.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 36 | 131 | $33,274 | $11,410 | 34.3% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 32 | 122 | $19,764 | $6,010 | 30.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 32 | 71 | $12,212 | $3,959 | 32.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 46 | 161 | $40,855 | $14,261 | 34.9% |
| 90833 | Psychotherapy performed with evaluation and management visit, 30 minutes | Office | 2021 | 38 | 148 | $22,459 | $7,860 | 35.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 33 | 74 | $12,684 | $4,469 | 35.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 47 | 112 | $19,040 | $5,178 | 27.2% |
| 90833 | Psychotherapy, 30 minutes | Office | 2020 | 30 | 85 | $10,625 | $4,337 | 40.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 25 | 59 | $14,927 | $3,834 | 25.7% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 22 | 29 | $5,800 | $2,217 | 38.2% |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | Office | 2020 | 13 | 13 | $455.00 | $111.60 | 24.5% |
About Dr. Jesse Wright, M.D
Dr. Jesse Wright, M.D is a Psychiatry healthcare provider based in Louisville, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1124090139.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jesse Wright, M.D has received a total of $4,616 in payments from pharmaceutical and medical device companies, with $25.88 received in 2024. These payments were reported across 4 transactions from 3 companies. The most common payment nature is "Consulting Fee" ($4,580).
As a Medicare-enrolled provider, Wright has provided services to 473 Medicare beneficiaries, totaling 1,409 services with total Medicare billing of $88,669. Data is available for 4 years (2020–2023), covering 14 distinct procedure/service records.
Practice Information
- Specialty Psychiatry
- Location Louisville, KY
- Active Since 02/03/2006
- Last Updated 11/03/2015
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1124090139
Products in Payments
- Photofrin (Drug) $25.88
- NUEDEXTA (Drug) $10.56
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Louisville
Rifaat Elmallakh, M.d, M.D
Psychiatry — Payments: $1.7M
Robert Stewart, M.d, M.D
Psychiatry — Payments: $652,603
Dr. Stephanie Hall, Md, MD
Psychiatry — Payments: $119,799
Kelly Clark, M.d, M.D
Psychiatry — Payments: $69,292
Dr. Ora Frankel, M.d, M.D
Psychiatry — Payments: $18,544
Dr. George Kalayil, M.d, M.D
Psychiatry — Payments: $11,878